SANI Membranes

SANI Membranes is a private, revenue-generating company providing a disruptive hardware platform for bioprocessing filtration. Its flagship Vibro® Membrane Filtration (VMF) technology uses targeted vibration to minimize membrane fouling, enabling higher yields, gentler product handling, and lower energy consumption compared to conventional tangential flow filtration. The technology is validated through independent academic research and has been trialed by industry players like Novozymes and Mipsalus. SANI operates in the Drug Delivery and Medical Devices sectors, offering scalable systems from lab-scale rentals to industrial units under an ISO 9001-certified quality management system.

Vibro® Membrane Filtration (VMF): A patented vibration-based micro- and ultrafiltration technology that uses localized vibrations to create targeted turbulence at the membrane surface, reducing fouling, enabling uniform transmembrane pressure, lowering shear stress, and improving process economy for sensitive biological products.

SANI Membranes competes in the bioprocessing filtration market dominated by large, established players like Merck Millipore (Pellicon), Cytiva (ÄKTA flux), Sartorius (Hydrosart), and Repligen (Spectrum). Its primary competitive differentiation is the vibration-based anti-fouling mechanism, which claims superior performance in reducing fouling, lowering shear, and improving energy efficiency compared to conventional Tangential Flow Filtration (TFF) systems.